🇺🇸 FDA
Patent

US 8530663

1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds

granted A61PA61P13/00A61P13/10

Quick answer

US patent 8530663 (1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds) held by Theravance, Inc. expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P13/00, A61P13/10, A61P15/12, A61P19/02